[1] Miller KL, Lanthier M.Innovation in biologic new molecular entities:1986-2014[J]. Nat Rev Drug Discov, 2015, 14(1):83. [2] Alonde ME, Durocher Y.Therapeutic glycoprotein production in mammalian cells[J]. J Biotechnol, 2017, 251(10):128-140. [3] Reusch D, Tejada ML.Fc glycans of therapeutic antibodies as critical quality attributes[J]. Glycobiology, 2015, 25(12):1325-1334. [4] Jefferis R.Recombinant antibody therapeutics:the impact of glycosylation on mechanisms of action[J]. Trends Pharmacol, 2009, 30(7):356-362. [5] Reinhart D, Damjanovic L, Kaisermayer C, et al.Benchmarking of commercially available cho cell culture media for antibody production[J]. Appl Microbiol Biot, 2015, 99(11):4645-4657. [6] Lee JH, Jeong YR, Kim YG, et al.Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture:N-glycosylation gene expression and N-linked glycan antennary profile[J]. Biotechnol Bioeng, 2017, 114(8):1721-1732. [7] 王晨, 汪嘉琪, 赵亮, 等. 二氧化碳分压和渗透压升高对CHO细胞维持期生长、代谢和产物表达的影响[J]. 生物技术通报, 2018, 34(3):217-224. [8] Gawlitzek M, Ryll T, Lofgren J, et al.Ammonium alters N-Glycan structures of recombinant TNFR-IgG:degradative versus biosynthetic mechanisms[J]. Biotechnol Bioeng, 2000, 68(6):637-646. [9] Schneider M, Marison IW, Von Stockar U.The importance of amm-onia in mammalian cell culture[J]. J Biotechnol, 1996, 46(3):161-185. [10] Mccracken NA, Kowle R, Ouyang A.Control of galactosylated glycoforms distribution in cell culture system[J]. Biotechnol Progr, 2014, 30(3):547-553. [11] Ha TK, Lee GM.Effect of glutamine substitution by TCA cycle intermediates on the production and sialylation of Fc-fusion protein in Chinese hamster ovary cell culture[J]. J Biotechnol, 2014, 180:23-29. [12] Rivinoja A, Hassinen A, Kokkonen N, et al.Elevated Golgi pH impairs terminal N-glycosylation by inducing mislocalization of golgi glycosyltransferases[J]. J Cell Physiol, 2009, 220(1):144-154. [13] Yang M, Butler M.Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation[J]. Biotechnol Bioeng, 2000, 68(4):370-380. [14] 孙祥明, 张元兴. 重组CHO细胞培养过程中氨对细胞代谢的影响[J]. 生物工程学报, 2001, 17(3):304-309. [15] Ha TK, Kim YG, Lee GM.Understanding of altered N-glycosyla-tion-related gene expression in recombinant Chinese hamster ovary cells subjected to elevated ammonium concentration by digital mRNA counting[J]. Biotechnol Bioeng, 2015, 112(8):1583-1593. [16] Ayyar BV, Arora S, Ravi SS.Optimizing antibody expression:The nuts and bolts[J]. Methods, 2017, 116(1):51-62. [17] Hossler P, Khattak SF, Li ZJ.Optimal and consistent protein glycosylation in mammalian cell culture[J]. Glycobiology, 2009, 19(9):936-949. [18] 谭文松, 孙亚婷, 赵亮. 适于动物细胞表达产品大规模生产的化学成分明确培养基[P]. 中国, CN 104328158 A, 2015-02-04. [19] Liu J, Chen X, Fan L, et al.Monitoring sialylation levels of Fc-fusion protein using size-exclusion chromatography as a process analytical technology tool[J]. Biotechnol Lett, 2015, 37(7):1371-1377. [20] Grainger RK, James DC.CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation. Biotechnol Bioeng, 2013, 110(11):2970-2983. [21] Hong J, Cho S, Yoon S.Substitution of glutamine by glutamate enh- ances production and galactosylation of recombinant IgG in Chinese hamster ovary cells[J]. Appl Microbiol Biot, 2010, 88(4):869-876. [22] Zhu J.Mammalian cell protein expression for biopharmaceutical production[J]. Biotechnol Adv, 2012, 30(5):1158-1170. [23] Wurm FM.Production of recombinant protein therapeutics in cultivated mammalian cells[J]. Nat Biotechnol, 2004, 22(11):1393-1398. [24] Liu L.Antibody glycosylation and its impact on the pharmacokine-tics and pharmacodynamics of monoclonal antibodies and fc-fusion proteins[J]. J Pharm Sci-US, 2015, 104(6):1866-1884. [25] Axelsson MAB, Karlsson NG, Steel DM, et al.Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins[J]. Glycobiology, 2001, 11(8):633-644. |